Skip to main content
Skip to footer

Reinstating the Pharma Supply Chain Post COVID-19 Pandemic Disruptions

Mithugopal Mandal

Senior Management Consultant, Life Sciences Advisory Services, TCS

You have these already downloaded

We have sent you a copy of the report to your email again.

The crisis has triggered the need for approaches that companies can take to circumvent challenges and get their production back on track

Supply chain is the backbone of pharma manufacturing. Global disruptions from COVID-19 pandemic have severely impacted the supply chains. Unless the organizations plan effectively, there is a chance it may take longer to recover than expected. This whitepaper addresses the key areas the organizations need to focus on and take the quick action.

 

About the Author

Mithugopal Mandal
Mithugopal is a Senior Management Consultant in TCS’ Life Science Advisory Practice.

Related reading

How the World Entered the Business of Human Microbiome

White Paper | 13 Nov 2022

Modernizing Pharma Regulatory Knowledge Management  

White Paper | 27 Oct 2022

Blockchain in pharma: Promoting a sustainable ecosystem

White Paper | 24 Oct 2022

Digital Strategy Framework for Life Sciences Companies

Solution | 11 Oct 2022

Transformation starts here

Integrated ecosystems are key to better patient outcomes.

Talk to our experts

Find out more